Serna A, Navarro V, Iacoboni G, Lopez L, et al. Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes. Haematologica 2024 Jul 11. doi: 10.3324/haematol.2024.285219.
PMID: 38988269